Suppr超能文献

无症状性反应性低血糖肥胖受试者的生长激素和皮质醇分泌

Secretion of growth hormone and cortisol in obese subjects with asymptomatic reactive hypoglycemia.

作者信息

Solter M, Sekso M

出版信息

Endokrinologie. 1980 Mar;75(2):216-24.

PMID:7398592
Abstract

Secretion of growth hormone and cortisol during 6-hour glucose tolerance test was investigated in obese subjects with asymptomatic reactive hypoglycemia (n = 27), obese controls (n = 22) and nonobese individuals (n = 18). Asymptomatic reactive hypoglycemia was defined as the presence of blood glucose value(s) of 40 mg/dl and below in the posthyperglycemic period of the test with no related symptoms. Growth hormone and cortisol levels following glucose nadir were significantly higher in obese asymptomatic hypoglycemics than in obese controls. Specific post-nadir increment (delta growth hormone) was higher in hypoglycemic (6.41 +/- 0.48/Mean +/- SE/) than in nonhypoglycemic obese subjects (1.04 +/- 0.28 ng/ml). Similar difference was found for delta cortisol (8.48 +/- 1.1 vs. -0.81 +/- 0.63 microgram/dl). In contrast to growth hormone, significant inverse proportion was found between delta cortisol and blood glucose nadir (i.e. the lower glucose nadintrols. Cortisol response seems to be more important in the diagnosis of previous hypoglycemic condition. Results suggest that obese subjects with asymptomatic reactive hypoglycemia are similar to manifest reactive hypoglycemics.

摘要

对患有无症状反应性低血糖的肥胖受试者(n = 27)、肥胖对照者(n = 22)和非肥胖个体(n = 18)在6小时葡萄糖耐量试验期间的生长激素和皮质醇分泌情况进行了研究。无症状反应性低血糖定义为在试验的高血糖期后血糖值为40mg/dl及以下且无相关症状。肥胖无症状低血糖患者在血糖最低点后的生长激素和皮质醇水平显著高于肥胖对照者。低血糖患者的特定最低点后增量(生长激素增量)(6.41±0.48/平均值±标准误/)高于非低血糖肥胖受试者(1.04±0.28ng/ml)。皮质醇增量(8.48±1.1对-0.81±0.63μg/dl)也发现了类似差异。与生长激素相反,皮质醇增量与血糖最低点之间存在显著的反比关系(即血糖最低点越低,皮质醇增量越高)。皮质醇反应在既往低血糖状况的诊断中似乎更为重要。结果表明,患有无症状反应性低血糖的肥胖受试者与明显的反应性低血糖患者相似。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验